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Implantation in Patients With Aortic Stenosis
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Pim de Feyter, MD, PHD,*† Patrick W. J. Serruys, MD, PHD,* Peter de Jaegere, MD, PHD*
Rotterdam, the Netherlands
Objectives Using multislice computed tomography (MSCT), we sought to evaluate the geometry and apposition of the CoreValve
ReValving System (CRS, Medtronic, Luxembourgh, Luxembourgh) in patients with aortic stenosis.
Background There are no data on the durability of percutaneous aortic valve replacement. Geometric factors may affect durability.
Methods Thirty patients had MSCT at a median 1.5 months (interquartile range [IQR] 0 to 7 months) after percutaneous aortic
valve replacement. Axial dimensions and apposition of the CRS were evaluated at 4 levels: 1) the ventricular end; 2)
the nadir; 3) central coaptation of the CRS leaflets; and 4) commissures. Orthogonal smallest and largest diameters
and cross-sectional surface area were measured at each level.
Results The CRS (26-mm: n  14, 29-mm: n  16) was implanted at 8.5 mm (IQR 5.2 to 11.0 mm) below the noncoronary
sinus. None of the CRS frames reached nominal dimensions. The difference between measured and nominal cross-
sectional surface area at the ventricular end was 1.6 cm2 (IQR 0.9 to 2.6 cm2) and 0.5 cm2 (IQR 0.2 to 0.7 cm2) at
central coaptation. At the level of central coaptation the CRS was undersized relative to the native annulus by 24%
(IQR 15% to 29%). The difference between the orthogonal smallest and largest diameters (degree of deformation) at
the ventricular end was 4.4 mm (IQR 3.3 to 6.4 mm) and it decreased progressively toward the outflow. Incomplete
apposition of the CRS frame was present in 62% of patients at the ventricular end and was ubiquitous at the central
coaptation and higher.
Conclusions Dual-source MSCT demonstrated incomplete and nonuniform expansion of the CRS frame, but the functionally
important mid-segment was well expanded and almost symmetrical. Undersizing and incomplete apposition
were seen in the majority of patients. (J Am Coll Cardiol 2009;54:911–8) © 2009 by the American College of
Cardiology Foundation
ublished by Elsevier Inc. doi:10.1016/j.jacc.2009.04.075p
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Pncreasing numbers of percutaneous aortic valve replace-
ent (PAVR) procedures are performed worldwide (1). At
resent there are no data on long-term valve durability,
hich may be determined by environmental factors (diabe-
es, renal insufficiency) and valve geometry (2).
When viewed axially the CoreValve ReValving system
CRS) (Medtronic, Luxembourgh) is round; the outflow
f the left ventricle (LVOT) is usually oval (3,4). This
ifference in geometry may lead to distortion of the valve
fter implantation. Distortion may also be caused by
rom the Departments of *Cardiology and †Radiology, Erasmus Medical Center,
otterdam, the Netherlands.u
Manuscript received February 26, 2009; revised manuscript received April 20,
009; accepted April 26, 2009.rosthesis-host mismatch due to inappropriate sizing or
ncomplete or nonuniform expansion owing to extensive
alcifications (5). Distortion of the valve may in turn
ffect leaflet configuration, which might cause valvular
egurgitation (6). In the absence of acute dysfunction,
neven distribution of stress on the leaflets may affect
ong-term durability (2).
The configuration (diameters and cross-sectional area)
nd apposition of the CRS were investigated using multi-
lice computed tomography (MSCT) in 30 patients treated
or aortic stenosis.
ethods
atients. The population consisted of 30 patients who
nderwent CRS implantation for aortic stenosis. MSCT
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CoreValve Geometry and Apposition by MSCT September 1, 2009:911–8was performed after PAVR in all
patients, 19 of whom had already
had a scan before PAVR. Writ-
ten informed consent was ob-
tained in all patients (post-
marketing surveillance registry).
The CRS (Fig. 1) and technique
of implantation have previously
been described in detail (1).
MSCT protocol. Dual-source
computed tomography was per-
formed similar to a coronary pro-
tocol described before but with-
o u t X - r a y t u b e c u r r e n t
modulation (100% of dose) (7).
Functional computed tomogra-
phy coronary angiography data-
sets were reconstructed using a
single-segmental reconstruction
lgorithm: slice thickness, 0.75 mm; increment, 0.4 mm;
edium-to-smooth convolution kernel (B26f); and sharp
ernel (B46f), resulting in a spatial resolution of 0.6 to 0.7
m in-plane and 0.4 to 0.5 mm through-plane. The
xpected radiation dose ranged between 8 and 20 mSv.
easures of interest on MSCT. With Siemens Circu-
ation software, the 3 perpendicular analysis windows
ere aligned to obtain 2 longitudinal slices and 1 axial
lice through the aortic root (pre-implantation) so that
he most caudal attachments of all 3 native aortic leaflets
ere seen simultaneously in 1 axial image, which was
hen defined as the native annulus (Fig. 2). At this level
he smallest diameter (oblique sagittal view) approxi-
Figure 1 CRS Structure and Levels of Interest
The CoreValve ReValving System (CRS) structure and the levels of interest (1, 2, 3
Abbreviations
and Acronyms
CRS  CoreValve
ReValving System
CSA  cross-sectional
surface area
D1  smallest diameter
D2  largest diameter
IQR  interquartile range
LVOT  left ventricular
outflow tract
MSCT  multislice
computed tomography
PAVR  percutaneous
aortic valve replacement
TTE  transthoracic
echocardiographyates the parasternal long-axis view on transthoracic
chocardiography (TTE); the largest diameter (oblique
oronal view) approximates the posteroanterior view on
ngiography (3).
Measurements of the CRS frame were done on axial
mages. The 3 perpendicular analysis windows were
ligned to obtain 2 longitudinal slices and 1 axial slice
hrough the CRS so that the welding points of the
entricular end appeared simultaneously in an axial image
Fig. 3).
We measured the smallest and largest perpendicular
iameters of the native aortic annulus and of the implanted
RS frame at: 1) the ventricular end where the CRS first
ppeared as a ring in the LVOT; 2) the nadir of the leaflets
ocated 1.5 cells (12 mm) above the ventricular end; 3) central
oaptation of the leaflets (3 cells or 24 mm above the
entricular end); and 4) the commissures (4 cells above the
entricular end) (Figs. 1 and 3).
At each axial level the perpendicular smallest (D1) and
argest (D2) diameters and cross-sectional surface area
CSA) were measured by connecting the middle of stent
truts. Deformation was calculated as the difference
etween D1 and D2. Axial morphology was defined as
oncircular if the ratio of D1/D2 was 10% or circular if
t was 10%. Apposition was visually assessed. The
ifference between measured and nominal diameters and
SA was calculated at the ventricular end and central
oaptation of the CRS. The variability of diameter
easurements (mean [SD]) at the level of central coap-
ation for D1 was 2% (1.0) or 0.4 mm; for D2 it was
.8% (1.8) or 0.4 mm; and for CSA it was 2% (1.8)
r 0.1 cm2.
t which dimensions were measured after implantation., 4) a
913JACC Vol. 54, No. 10, 2009 Schultz et al.
September 1, 2009:911–8 CoreValve Geometry and Apposition by MSCTFigure 2 Native Aortic Root on MSCT
The axial plane of the native aortic valve on multislice computed tomography (MSCT) and corresponding orientation of an anatomical specimen. The most caudal attach-
ment of all 3 aortic leaflets can be seen in one axial image. The anatomical image is from W.A. Mcalpine. Heart and Coronary Arteries: An Anatomical Atlas for Clinical
Diagnosis, Radiological Investigation, and Surgical Treatment. Springer Verlag; October 1974. LAFT  left anterior fibrous trigone; LCA  left coronary artery; RAFT 
right anterior fibrous trigone; RCA  right coronary artery; TV  tricuspid valve.Figure 3 Levels of Measurement of the CRS on MSCT
The appearance of the CRS is shown on MSCT (coronal cut plane) after implantation and levels (1, 2, 3, 4)
where the dimensions were measured. CRS  CoreValve ReValving System; MSCT  multislice computed tomography.
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CoreValve Geometry and Apposition by MSCT September 1, 2009:911–8The depth of implantation was measured from the
entricular end of the CRS to the floor of the noncoronary
inus (8). The noncoronary sinus was used as a reference
oint to guide the positioning of the CRS valve under
uoroscopy.
tatistical methods. Variables not normally distributed are
iven as a median and interquartile range (IQR). Paired
ata were compared using the Wilcoxon signed rank test.
tatistical significance was defined as p  0.01.
esults
atient characteristics are shown in Table 1. The median
linical Characteristics of the Study PopulationTable 1 Clinical Characteristics of the Study Population
Characteristic MSCT Post-Implant
n, male/female 16/14
Age, yrs 81 (73–84)
Height, cm 166 (160–173)
Weight, kg 73 (63–80)
NYHA functional class 3 (3–3)
Logistic Euroscore 13 (8–16)
Antecedents
Stroke/transient ischemic attack 5 (17)
Myocardial infarction 5 (17)
Coronary bypass surgery 9 (30)
Percutaneous coronay intervention 8 (27)
Peripheral vascular disease 1 (3)
Comorbidity
Diabetes 4 (13)
Chronic obstructive pulmonary disease 7 (23)
Serum creatinine, mg/dl 1.08 (0.93–1.46)
Echo Doppler
Left ventricular function*
Normal 17 (57)
Moderate 13 (43)
Impaired 0 (0)
Peak transaortic velocity
Pre-procedure 4.5 (4.0–4.8)
Post-procedure 2.2 (1.7–2.4)
Calcification of aortic root, Agatston score 2,839 (2,024–5,001)
Procedure
CRS 26 14 (47)
CRS 29 16 (53)
Number CRS implanted
1 valve 28 (93)
1 valve 2 (7)
PABV after CRS 5 (17)
Duration between PAVR implant and MSCT, months 1.5 (0–7)
ata are reported as n (%), mean (SD), or median (interquartile range). *Left ventricular function
as determined by visual assessment of the baseline transthoracic echocardiogram and classified
s normal in case of an estimated ejection fraction of 50%, moderate if 30% to 50%, and poor
f 30%.
CRS  CoreValve ReValving System; MSCT multislice computer tomography; NYHA  New York
eart Association; PABV  percutaneous aortic balloon valvuloplasty; PAVR  percutaneous aortic
alve replacement.epth of implantation was 8.5 mm (IQR 5.2 to 11.2 mm)
i
Telow the noncoronary sinus. Therefore, coaptation of
he CRS leaflets was supra-annular in all patients.
rosthesis size and expansion. Prosthesis size and expan-
ion is shown in Tables 2 to 5. None of the frames reached
he nominal dimensions at either the ventricular end or the
entral coaptation. The difference in CSA at the ventricular
iameter and Cross-Sectional Area Measuredy MSCT t the Ventricular End of the CRS*Table 2 Diam ter and Cross-Sectional Area Measuredby MSCT at the Ventricular End of the CRS*
CRS Native Aortic Root
Patient
#
D1,
mm
D2,
mm
D2-D1,
mm
CSA,
cm2
D1,
mm
D2,
mm
D2-D1,
mm
CSA,
cm2
26-mm
inflow
valve
1 17.9 21.3 3.40 2.92 17.6 22.1 4.5 3.18
2 20.0 22.4 2.40 3.40 18.7 20.9 2.2 3.08
3† 15.3 19.2 3.90 2.31 19.2 23.6 4.4 3.64
4 20.8 25.8 5.00 4.19 19.5 24.6 5.1 3.83
5 18.9 26.4 7.50 4.04 19.6 25.3 5.7 4.15
6‡ 22.6 26.6 4.00 4.79 20.0 24.9 4.9 3.96
7† 13.9 22.2 8.30 2.56 22.2 27.4 5.2 5.13
8 22.4 24.6 2.20 4.42 22.7 25.5 2.8 4.57
9 23.7 26.1 2.40 4.91 23.9 26.4 2.5 4.98
10 19.3 24.3 5.00 3.52 18.5 23.1 2.0 5.74
11 19.0 23.4 4.40 3.63
12 18.2 24.6 6.40 3.68
13 19.2 26.0 6.80 3.70
14 22.5 26.4 3.90 4.79
29-mm
inflow
valve
15 20.8 25.2 4.40 4.07 19.7 24.3 4.6 3.81
16 21.2 24.9 3.70 3.91 22.2 26.2 4.0 4.61
17‡ 24.6 29.0 4.40 5.67 22.3 28.3 6.0 4.95
18§ 21.3 30.3 9.00 5.10 22.3 27.9 5.6 4.62
19‡ 25.1 29.5 4.40 5.99 22.7 32.5 9.8 5.49
20† 18.1 26.9 8.80 3.91 22.8 24.9 2.1 4.48
21 20.8 24.4 3.60 4.03 25.9 29.1 3.2 5.95
22 25.3 28.3 3.00 5.75 26.1 28.5 2.4 5.86
23 25.4 29.7 4.30 5.85 26.3 28.5 2.2 5.91
24 19.4 25.8 6.40 3.96
25 18.3 25.2 6.90 3.69
26 24.3 25.9 1.60 5.27
27 20.3 23.6 3.30 3.60
28 25.3 27.4 2.10 5.56
29 25.7 28.8 3.10 5.75
30 17.9 26.5 8.60 3.92
Median
(IQR)
20.8
(19.0–
23.4)
25.9
(24.5–
26.9)
4.4
(3.3–
6.4)
4.0
(3.7–
5.1)
22.2
(19.6–
22.8)
26.2
(24.8–
28.1)
4.4
(2.5–
5.1)
4.6
(3.9–
5.3)
D1 corresponds with the sagittal (anterior-posterior) diameter and D2 with the coronal (left to
ight) diameter on MSCT. CSA of a 26-mm inflow valve  5.3 cm2, CSA of a 29-mm inflow
alve  6.6 cm2. †High implant (ventricular end 1 mm below the noncoronary sinus, heavily
alcified restrictive leaflets). ‡Positioned very low, 12 mm below the noncoronary sinus
ventricular end in section of LVOT that widens into the LV). §Deformation caused by unusually
val annulus.
CSA  cross-sectional surface area; D1  smallest diameter; D2  largest diameter; IQR nterquartile range; LV left ventricular; LVOT left ventricular outflow tract; other abbreviations as in
able 1.
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September 1, 2009:911–8 CoreValve Geometry and Apposition by MSCTnd was 1.6 cm2 (IQR 0.9 to 2.6 cm2), and 0.5 cm2 (IQR
.2 to 0.7 cm2) at the central coaptation.
In 19 patients in whom the native annulus was mea-
ured, CRS dimensions conformed to the native annulus
imensions in 11; in 3 patients in whom the CRS was
mplanted relatively high, there was underexpansion due
o calcified native leaflets (Patients #3, #7, and #20). In
nother 3 patients in whom the CRS was implanted
elatively low, the ventricular end was positioned below
he annulus in a wider section of the LVOT (Patients #6,
17, and #19).
Patient to prosthesis sizing was estimated by comparing
he CSA at the anatomical and functional narrowest point
f the CRS (central coaptation) with the CSA of the native
nnulus. The CRS was anatomically undersized by 24%
iameter and Cross-Sectional Area Measured bySCT at the Level of the Nadir of the CRS LeafletsTable 3 Diameter and Cross-Sectional Area Measured byMSCT at the Level of the Nadir of the CRS Leaflets
CRS
Patient #
D1,
mm
D2,
mm
D2-D1,
mm
CSA,
cm2
26-mm inflow valve
1 20.0 22.3 2.3 3.53
2 20.3 23.0 2.7 3.67
3 17.1 23.5 6.4 3.30
4 21.4 23.1 1.7 3.80
5 18.7 22.1 3.4 3.30
6 19.6 20.9 1.3 3.35
7 17.3 23.7 6.4 3.43
8 21.1 23.8 2.7 4.00
9 21.8 23.7 1.9 4.10
10 20.1 22.8 2.7 3.48
11 19.4 23.4 4.0 3.72
12 19.7 25.1 5.4 3.87
13 19.6 25.1 5.5 3.83
14 20.5 22.8 2.3 3.71
29-mm inflow valve
15 19.7 22.8 3.1 3.47
16 20.8 23.7 2.9 3.88
17 22.6 24.6 2.0 4.36
18 19.6 26.9 7.3 4.21
19 22.0 25.9 3.9 4.55
20 21.4 26.2 4.8 4.50
21 20.3 23.6 3.3 3.90
22 22.4 24.8 2.4 4.49
23 23.5 24.6 1.1 4.59
24 19.2 24.2 5.0 3.66
25 20.6 26.3 5.7 4.37
26 21.3 25.5 4.2 4.44
27 20.2 25.2 5.0 3.98
28 23.5 25.1 1.6 4.54
29 23.4 24.8 1.4 4.62
30 18.4 26.0 7.6 3.86
Median (IQR) 20.3
(19.6–21.4)
24.0
(23.2–25.1)
3.2
(2.3–5.0)
3.9
(3.7–4.4)
bbreviations as in Tables 1 and 2.IQR 15% to 29%).
mrosthesis deformation. The differences between the D1
nd D2 measurements are given in Tables 2 to 5. Symmet-
ical expansion was seen in only 5 patients and then only at
he levels of central coaptation and commissures. The
egree of deformation was maximal at the ventricular end
median difference: 4.4 mm [IQR 3.3 to 6.4 mm]), less at
he nadir of the CRS leaflets (3.2 mm [IQR 2.3 to 5.0
m]), and decreased progressively toward the commissures,
iameter and Cross-Sectional Area Measured bySCT at the Level of the Central Coaptation of theRS Leaflets*
Table 4
Diameter and Cross-Sectional Area M asured by
MSCT at the Level of the Central Coaptation of the
CRS Leaflets*
CRS
Transthoracic Echo at
Time of Follow-Up
MSCT
Patient
#
D1,
mm
D2,
mm
D2-D1,
mm
CSA,
cm2
Peak
Velocity,
m/s
Estimated
Orifice Area,
cm2
26-mm
inflow
valve
1 20.8 22.0 1.2 3.62 2.03 1.46
2 20.3 22.7 2.4 3.70 2 2.07
3 19.5 23.0 3.5 3.63 2.1 †
4 20.7 21.3 0.6 3.56 2 1.61
5 19.5 19.6 0.1 3.01 2.4 1.77
6 19.0 20.8 1.8 3.18 2.3 †
7 20.3 22.9 2.6 3.78 2.3 †
8 20.5 21.9 1.4 3.57 2.29 1.10
9 20.0 21.0 1.0 3.45 1.79 1.87
10 21.0 21.7 0.7 3.56 2.30 2.64
11 19.0 22.0 3.0 3.31 1.95 1.12
12 20.2 23.1 2.9 3.70 1.80 1.27
13 20.3 22.2 1.9 3.62 2.01 1.86
14 19.3 22.0 2.7 3.47 1.56 †
29-mm
inflow
valve
15 18.6 22.3 3.7 3.26 2.35 †
16 21.0 23.2 2.2 3.87 1.78 †
17 21.3 22.7 1.4 3.73 2.00 1.78
18 19.3 23.5 4.2 3.53 2.16 1.70
19 21.4 23.1 1.7 3.93 1.6 †
20 21.0 25.0 4.0 4.23 2.50 1.42
21 20.8 24.1 3.3 3.92 1.56 1.56
22 23.0 23.6 0.6 4.31 2.45 1.53
23 22.7 23.6 0.9 4.17 2.10 2.27
24 21.3 24.0 2.7 3.97 2.90 1.89
25 20.5 25.3 4.8 4.12 1.50 3.37
26 20.0 23.2 3.2 4.02 2.10 1.58
27 20.5 23.8 3.3 3.80 1.50 1.38
28 22.2 22.3 0.1 3.87 2 1.05
29 20.0 22.1 2.1 3.61 2.5 1.50
30 19.0 23.4 4.4 3.58 1.7 †
Median
(IQR)
20.4
(19.6–
21)
22.8
(22–
23.5)
2.3
(1.3–
3.3)
3.7
(3.6–
3.9)
2.0
(1.8–
2.3)
1.60
(1.43–1.85)
Nominal diameter at the level of central coaptation of 26- and 29-mm inflow valves are 22 and 24
2m, respectively, and the nominal CSAs are 3.8 and 4.5 cm , respectively. †Data not available.
Abbreviations as in Tables 1 and 2.
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CoreValve Geometry and Apposition by MSCT September 1, 2009:911–8here it was 1.1 mm (IQR 0.5 to 1.7 mm) (Figs. 4 and 5).
onfiguration of the CRS in the axial plane at the 4 levels
s given in Table 6 and Figures 4 and 6.
rosthesis apposition. The ventricular end of the CRS
as apposed to adjacent tissues in 10 patients, partially
pposed (not for30% of the circumference) in another 16,
iameter and Cross-Sectional Area Measuredy MSCT t the Level of the Commissures of theRS Leafle s
Table 5
Diam t r and Cross-Sectional Area Measured
by MSCT at the Level of the Commissures of the
CRS Leaflets
CRS
Patient #
D1,
mm
D2,
mm
D2-D1,
mm
CSA,
cm2
26-mm inflow valve
1 * * * *
2 27.2 28.5 1.3 6.0
3 26.4 26.9 0.5 5.8
4 26.0 26.3 0.3 5.5
5 22.4 24.0 1.6 4.3
6 * * * *
7 26.9 27.8 0.9 6.1
8 24.3 25.7 1.4 4.7
9 26.3 26.8 0.5 5.6
10 26.0 28.1 2.1 5.9
11 25.2 26.1 0.9 5.1
12 26.8 27.9 1.1 5.9
13 26.8 27.3 0.5 5.8
14 22.5 24.4 1.9 4.4
29-mm inflow valve
15 26.4 28.7 2.3 5.9
16 29.4 30.7 1.3 7.3
17 29.5 30.8 1.3 7.1
18 26.2 27.0 0.8 5.5
19 28.2 29.3 1.1 6.6
20 28.2 30.9 2.7 7.0
21 30.8 31.9 1.1 7.9
22 31.1 31.2 0.1 7.9
23 29.3 30.2 0.9 7.0
24 33.0 33.4 0.4 8.8
25 32.2 34.8 2.6 9.2
26 26.2 28.6 2.4 6.1
27 27.8 28.2 0.4 6.3
28 29.3 29.0 0.3 6.8
29 25.7 27.8 2.1 5.5
30 26.7 27.6 0.9 5.9
Median (IQR) 26.8 28.2 1.1 6.0
(26.2–29.3) (27.0–30.3) (0.5–1.7) (5.6–7.0)
Accurate measurements were not possible for technical reasons.
Abbreviations as in Tables 1 and 2.
xial Shape of the CRS at thearious Levels as Assessed VisuallyTable 6 Axial Shape of the CRS at theVarious Levels as Assessed Visually
Shape
Ventricular
End
Nadir of
Leaflets
Central
Coaptation Commissures
Circular, n 4 10 15 28*
Noncircular, n 26 20 15 0*dotal n  30 patients. *Could not be assessed in 2 patients.nd could not be assessed in 5. Partial apposition was due to
relatively low implantation in 9 patients and constraining
y the calcified leaflets in 6 others with a relatively high
mplantation (Fig. 4).
At the nadir of the CRS leaflets the frame was well
pposed to the compressed native leaflets. At the central
oaptation and higher, large sections of the CRS were not
pposed to the surrounding tissues. Malapposition at the
entricular end of the CRS was not associated with signif-
cant aortic regurgitation on TTE (Table 7).
iscussion
e found that there was incomplete and nonuniform expan-
ion of the frame at all levels. The asymmetry of the ventricular
nd is explained by conformation of the CRS to the noncir-
ular anatomy of the LVOT (3,4). This is underscored by the
bservation that in 11 of the 12 patients with both an average
epth of implantation and a pre-procedural MSCT, the
imensions of the base of the CRS and the recipient aortic
oot were similar. The incomplete and nonuniform expan-
ion of the ventricular end may anchor the CRS in the
VOT, thereby facilitating the apposition of the skirt and
reventing paravalvar regurgitation (1). The calcified native
eaflets may have contributed to the restriction of expansion
nd anchoring of the CRS, similar to the Edwards-Sapien
alve (9).
The middle segment of the CRS, which hosts the
eaflets, was less deformed and more apposed at its lower
nd. This segment is both constrained and highly resis-
ant to external compression in order to preserve the
ptimal geometry and coaptation of the leaflets. This
egment of the CRS was positioned at the narrowest
ection of the native aortic root (calcified leaflets). This
ay explain the deformation seen despite the high hoop
trength. Zegdi et al. (6) demonstrated, in an acute
xperiment with a valve of different origin to the CRS
nd with leaflets residing in the anchoring area of the
rame, that deformation of the frame affects the config-
ration of the leaflets. In the absence of immediate valve
ncomplete Apposition at the Ventricular End ofhe CRS Was N t Associa ed With Significantortic R gurgita ion (>Grad 2 of 4) asssessed by Tr ns horacic Echocard og aphymmediatel Pos -Pr cedur *
Table 7
Incomplete Apposition at the Ventricular End of
the CRS Was Not Associated With Significant
Aortic Regurgitation (>Grade 2 of 4) as
Assessed by Transthoracic Echocardiography
Immediately Post-Procedure*
Aortic
Regurgitation
Post-Procedure
<1, n >2†, n
Incomplete apposition of the CRS at the
ventricular end (at least 30° of circumference)
Yes 13 4
No 5 3
Apposition of the CRS could not be assessed in 5 patients due to insufficient contrast opacifica-
ion. Significant aortic regurgitation was paravalvular in all cases. †No patient had aortic regurgi-
ation higher than grade 2.ysfunction, the asymmetrical stresses so induced may
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September 1, 2009:911–8 CoreValve Geometry and Apposition by MSCTffect durability (2,6). Whether the deformation observed
t the level of the nadir of the CRS leaflets in this study
ill affect durability requires further study.
Only minimal deformation and underexpansion was seen
t the level at which the leaflets coapt. This is explained by
he supra-annular position above the calcified native leaflets
n combination with the high hoop strength. The midsec-
ion is constrained relative to the ventricular end and
herefore some anatomical undersizing may be present (on
verage, by 24% anatomically in this series). The effective
Figure 4 Axial Morphology of the CRS
The morphology of the CRS at the levels of interest (1, 2, 3) in 3 patients, where
within the aortic root was close to the median, lower, or higher. CRS  CoreValve
Figure 5 Degree of Asymmetry at the VariousmSegments of the CoreValve ReValving Systemrifice area was smaller than the anatomical orifice area in all
atients and is clinically more relevant than anatomical or
eometric data alone (10,11). The effects of undersizing
emain to be evaluated and may be particularly relevant if
AVR is performed in younger patients.
Incomplete apposition of at least 30% of the ventricular
nd circumference was seen in 61% of patients. Possible
xplanations are a relatively high or low position within
he LVOT and constraining by calcific native leaflets. We
id not observe any association between incomplete
pposition of the CRS at the ventricular end and aortic
egurgitation. It remains to be elucidated whether incom-
lete apposition is associated with a higher risk of
hromboembolism (12).
tudy limitations. This study is limited by a small
ample of selected patients who underwent MSCT. We
bserved incomplete and nonuniform expansion of the
RS frame at the ventricular end, in particular. There
as some degree of anatomical undersizing due to the
nique design of the CRS. Incomplete apposition of
truts in the left ventricular outflow and along the length
f the CRS was ubiquitous. Further studies to determine
ong-term effects are required. Yet, detailed assessment of
he position and the geometry of the frame in other
eports led to a higher implantation strategy to avoid the
ew left bundle branch block and affect patient manage-
sition
ving System.the po
ReValent (8,13).
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